These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 32765142)

  • 1. Living with Narcolepsy: Current Management Strategies, Future Prospects, and Overlooked Real-Life Concerns.
    Barker EC; Flygare J; Paruthi S; Sharkey KM
    Nat Sci Sleep; 2020; 12():453-466. PubMed ID: 32765142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.
    Thorpy MJ; Bogan RK
    Sleep Med; 2020 Apr; 68():97-109. PubMed ID: 32032921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in treatment of narcolepsy].
    Xu Q; Lou G; Wang T; Zhang L
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 Aug; 49(4):419-424. PubMed ID: 32985153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recently Approved and Upcoming Treatments for Narcolepsy.
    Thorpy MJ
    CNS Drugs; 2020 Jan; 34(1):9-27. PubMed ID: 31953791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pitolisant, a novel histamine-3 receptor competitive antagonist, and inverse agonist, in the treatment of excessive daytime sleepiness in adult patients with narcolepsy.
    Sarfraz N; Okuampa D; Hansen H; Alvarez M; Cornett EM; Kakazu J; Kaye AM; Kaye AD
    Health Psychol Res; 2022; 10(3):34222. PubMed ID: 35774905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Narcolepsy in the older adult: epidemiology, diagnosis and management.
    Chakravorty SS; Rye DB
    Drugs Aging; 2003; 20(5):361-76. PubMed ID: 12696996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium, Magnesium, Potassium and Sodium Oxybates (Xywav
    Heo YA
    CNS Drugs; 2022 May; 36(5):541-549. PubMed ID: 35357671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of sodium oxybate as a treatment option for narcolepsy.
    Abad VC
    Expert Opin Pharmacother; 2019 Jul; 20(10):1189-1199. PubMed ID: 31136215
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of a lower-sodium oxybate formulation for the treatment of patients with narcolepsy and idiopathic hypersomnia.
    Junnarkar G; Allphin C; Profant J; Steininger TL; Chen C; Zomorodi K; Skowronski R; Black J
    Expert Opin Drug Discov; 2022 Feb; 17(2):109-119. PubMed ID: 34818123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating pitolisant as a narcolepsy treatment option.
    de Biase S; Pellitteri G; Gigli GL; Valente M
    Expert Opin Pharmacother; 2021 Feb; 22(2):155-162. PubMed ID: 32941089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological management of narcolepsy with and without cataplexy.
    Kallweit U; Bassetti CL
    Expert Opin Pharmacother; 2017 Jun; 18(8):809-817. PubMed ID: 28443381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profile of Solriamfetol in the Management of Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea: Focus on Patient Selection and Perspectives.
    Abad VC
    Nat Sci Sleep; 2021; 13():75-91. PubMed ID: 33531850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging treatments for narcolepsy and its related disorders.
    Nishino S; Okuro M
    Expert Opin Emerg Drugs; 2010 Mar; 15(1):139-58. PubMed ID: 20166851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solriamfetol for the Use of Narcolepsy: A Systematic Review.
    Iturburu A; Pallares Vela E; Cruz C; Yepez M; Ortiz JF; Krishna K; Peña G; Cordova S; Khurana M; Bandarupalli P
    Cureus; 2022 May; 14(5):e24937. PubMed ID: 35706734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility.
    Guevarra JT; Hiensch R; Varga AW; Rapoport DM
    Nat Sci Sleep; 2020; 12():709-719. PubMed ID: 33117007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy.
    Pérez-Carbonell L
    Curr Treat Options Neurol; 2019 Nov; 21(11):57. PubMed ID: 31713736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in the management of narcolepsy.
    Abad VC; Guilleminault C
    Nat Sci Sleep; 2017; 9():39-57. PubMed ID: 28424564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.
    Szabo ST; Thorpy MJ; Mayer G; Peever JH; Kilduff TS
    Sleep Med Rev; 2019 Feb; 43():23-36. PubMed ID: 30503715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Excessive Daytime Sleepiness in Narcolepsy With Baclofen.
    Morse AM; Kelly-Pieper K; Kothare SV
    Pediatr Neurol; 2019 Apr; 93():39-42. PubMed ID: 30595352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.